Media Summary: Drs. Richard Barohn and Jeff Statland, both physicians at the University of Kansas Dr. Hani Kushlaf, Neurologist from University of Cincinnati Medical Center gives his presentation on Research and Dr. Mazen Dimachkie, Professor and Executive Vice Chair, Vice Chair for

Neuromuscular Diseases And Clinical Trials - Detailed Analysis & Overview

Drs. Richard Barohn and Jeff Statland, both physicians at the University of Kansas Dr. Hani Kushlaf, Neurologist from University of Cincinnati Medical Center gives his presentation on Research and Dr. Mazen Dimachkie, Professor and Executive Vice Chair, Vice Chair for Dr. Terry Heiman-Patterson, Neurologist, Temple University Description: Dr. Terry Heiman-Patterson, Neurologist from Temple ... There are more than 600 types of neurologic and With many potential drugs and treatments in development, this session explores the different stages of the

Dr Michelle Farrar – MBBS, FRACP, PhD - Paediatric Neurologist and director of Dr. Rosario Maria Riel-Romero, Child Neurologist, Professor of Neurology from Louisiana State University School of Medicine ... NSGR: Therapeutic Advancements in Pediatric For more about brain and spine care at Ohio State, visit ... Nicholas Maragakis, director of the Johns Hopkins ALS Center for Cell Therapy and Regeneration Dr. Saurabh Shukla, University of Mississippi

Jerry Mendell, MD, FAAN, Nationwide Children's Hospital & Ohio State University, Columbus, OH, gives an overview of gene ... Cathy Turner, Project Manager for DMD Care UK at the John Walton Nizar Souayah, MD, FAAN, Rutgers New Jersey

Photo Gallery

Neuromuscular diseases and clinical trials
Research and Clinical Trial Reviews for Neuromuscular Disease
Noteworthy Research and Clinical Trials in Adults with Neuromusuclar Disease
Updates in Neuromuscular Research and Clinical Trials
Neurological and Neuromuscular Diseases: Mayo Clinic Radio
What Comes Next: Preparing for DM Clinical Trials
Lessons learned from SMA – what happens when a clinical trial works!
Best Clinical Practices in Neuromuscular Disorders
NSGR: Therapeutic Advancements in Pediatric Neuromuscular Disorders, led by Clara Chow Haws, MD
Hope on the Horizon: Trials, Treatments and Therapies for Duchenne muscular dystrophy
What is a neuromuscular disorder? | Ohio State Medical Center
NurOwn - Phase 2 Clinical Trial with Dr. Namita Goyal, MD
Sponsored
Sponsored
View Detailed Profile
Neuromuscular diseases and clinical trials

Neuromuscular diseases and clinical trials

Drs. Richard Barohn and Jeff Statland, both physicians at the University of Kansas

Research and Clinical Trial Reviews for Neuromuscular Disease

Research and Clinical Trial Reviews for Neuromuscular Disease

Dr. Hani Kushlaf, Neurologist from University of Cincinnati Medical Center gives his presentation on Research and

Sponsored
Noteworthy Research and Clinical Trials in Adults with Neuromusuclar Disease

Noteworthy Research and Clinical Trials in Adults with Neuromusuclar Disease

Dr. Mazen Dimachkie, Professor and Executive Vice Chair, Vice Chair for

Updates in Neuromuscular Research and Clinical Trials

Updates in Neuromuscular Research and Clinical Trials

Dr. Terry Heiman-Patterson, Neurologist, Temple University Description: Dr. Terry Heiman-Patterson, Neurologist from Temple ...

Neurological and Neuromuscular Diseases: Mayo Clinic Radio

Neurological and Neuromuscular Diseases: Mayo Clinic Radio

There are more than 600 types of neurologic and

Sponsored
What Comes Next: Preparing for DM Clinical Trials

What Comes Next: Preparing for DM Clinical Trials

With many potential drugs and treatments in development, this session explores the different stages of the

Lessons learned from SMA – what happens when a clinical trial works!

Lessons learned from SMA – what happens when a clinical trial works!

Dr Michelle Farrar – MBBS, FRACP, PhD - Paediatric Neurologist and director of

Best Clinical Practices in Neuromuscular Disorders

Best Clinical Practices in Neuromuscular Disorders

Dr. Rosario Maria Riel-Romero, Child Neurologist, Professor of Neurology from Louisiana State University School of Medicine ...

NSGR: Therapeutic Advancements in Pediatric Neuromuscular Disorders, led by Clara Chow Haws, MD

NSGR: Therapeutic Advancements in Pediatric Neuromuscular Disorders, led by Clara Chow Haws, MD

NSGR: Therapeutic Advancements in Pediatric

Hope on the Horizon: Trials, Treatments and Therapies for Duchenne muscular dystrophy

Hope on the Horizon: Trials, Treatments and Therapies for Duchenne muscular dystrophy

Muscular Dystrophy

What is a neuromuscular disorder? | Ohio State Medical Center

What is a neuromuscular disorder? | Ohio State Medical Center

For more about brain and spine care at Ohio State, visit ...

NurOwn - Phase 2 Clinical Trial with Dr. Namita Goyal, MD

NurOwn - Phase 2 Clinical Trial with Dr. Namita Goyal, MD

She also is an investigator in several

#LetsTalkNMD Webinar - Voice in Research: Neuromuscular Disease Clinical Trials

#LetsTalkNMD Webinar - Voice in Research: Neuromuscular Disease Clinical Trials

Muscular Dystrophy

The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

The Expanding Landscape of Therapeutic Targets in ALS Clinical Trials

Nicholas Maragakis, director of the Johns Hopkins ALS Center for Cell Therapy and Regeneration

Namita Goyal Intro - Neuromuscular Disorders: The BrainStorm Stem Cell Trial to Treat ALS

Namita Goyal Intro - Neuromuscular Disorders: The BrainStorm Stem Cell Trial to Treat ALS

Watch the full lecture here: https://youtu.be/f99q0r9luaU.

Clinical Trials and Research Updates in Neuromuscular Care

Clinical Trials and Research Updates in Neuromuscular Care

Dr. Saurabh Shukla, University of Mississippi

The progress in gene therapy in neuromuscular diseases since its first clinical use

The progress in gene therapy in neuromuscular diseases since its first clinical use

Jerry Mendell, MD, FAAN, Nationwide Children's Hospital & Ohio State University, Columbus, OH, gives an overview of gene ...

The TREAT-NMD Advisory Committee for Therapeutics (TACT)

The TREAT-NMD Advisory Committee for Therapeutics (TACT)

Cathy Turner, Project Manager for DMD Care UK at the John Walton

Current and Emerging Clinical Trials for CMT

Current and Emerging Clinical Trials for CMT

Vera Kiyasova, PhD, Director of

Should placebo-controlled trials be used in neuromuscular disease?

Should placebo-controlled trials be used in neuromuscular disease?

Nizar Souayah, MD, FAAN, Rutgers New Jersey